| Page 25 | Kisaco Research
 

Dr. Eliezer Katz

CMO
Eledon Pharmaceuticals

Dr. Katz is an experienced transplant surgeon and a leader in clinical development in the pharmaceutical industry. Currently, Dr. Katz is the chief medical officer of Eledon Pharmaceutical. Before joining Eledon, Dr. Katz was CMO of eGenesis, a company in the xenotransplantation field. Previously, Dr. Katz served as Vice President and clinical development lead at Viela Bio and Horizon Therapeutics, where he was responsible for developing novel medications for autoimmune-related diseases and organ transplantation.

Dr. Eliezer Katz

CMO
Eledon Pharmaceuticals

Dr. Eliezer Katz

CMO
Eledon Pharmaceuticals

Dr. Katz is an experienced transplant surgeon and a leader in clinical development in the pharmaceutical industry. Currently, Dr. Katz is the chief medical officer of Eledon Pharmaceutical. Before joining Eledon, Dr. Katz was CMO of eGenesis, a company in the xenotransplantation field. Previously, Dr. Katz served as Vice President and clinical development lead at Viela Bio and Horizon Therapeutics, where he was responsible for developing novel medications for autoimmune-related diseases and organ transplantation.
Dr. Katz earned his MD degree from the Hebrew University-Hadassah Medical School in Jerusalem, Israel.
Dr. Katz joined Viela Bio/Horizon following 30 years of combined academic and pharmaceutical career in the areas of organ transplantation, immunology, and immune-induced diseases.
His academic career as a transplant surgeon spanned 20 years, including directorship of two transplantation programs. The director of the abdominal transplantation division at Integris Baptist Medical Center in Oklahoma City, and an associate professor of surgery and the director of the liver transplantation division at the University of Massachusetts Medical Center, Worcester, MA. During his tenure as a transplant surgeon, Dr. Katz implemented techniques for split liver and living donor liver transplantation, was actively involved in policy making related to organ donation and allocation and led efforts to increase organ donation.
After joining the pharmaceutical industry, Dr. Katz served as the vice president at CTI clinical trial and consulting services, as senior director in transplantation at Medicine Development Group, Pfizer Inc., and at Medimmune/AstraZeneca as a senior director at RIA (respiratory, inflammation, and autoimmunity), where he oversaw clinical development in neuro-inflammation, inflammatory bowel disease, and myositis.
Dr. Katz is an author of more than 60 peer-reviewed publications.

 

Martha Scott Poindexter

CEO
Animal Health Institute

Martha Scott Poindexter

CEO
Animal Health Institute

Martha Scott Poindexter

CEO
Animal Health Institute
 

Richard Kestenbaum

Retail Correspondent
Forbes

Richard Kestenbaum

Retail Correspondent
Forbes

Richard Kestenbaum

Retail Correspondent
Forbes
 

William Propst

Managing Director
Jones Lang LaSalle

Richard is a co-founder and Partner of Triangle Capital and has been an investment banker for over 35 years. Richard has a great deal of experience advising clients in merchandising businesses, particularly in the Retail & Consumer sector.  Richard is an often-quoted expert on the retail and merchandising industries. He is a Contributor to Forbes.com where he writes a regular blog about trends in retail and consumer product businesses. He also appears regularly in print and other media as well as industry panels and speaking programs.  

William Propst

Managing Director
Jones Lang LaSalle

William Propst

Managing Director
Jones Lang LaSalle

Richard is a co-founder and Partner of Triangle Capital and has been an investment banker for over 35 years. Richard has a great deal of experience advising clients in merchandising businesses, particularly in the Retail & Consumer sector.  Richard is an often-quoted expert on the retail and merchandising industries. He is a Contributor to Forbes.com where he writes a regular blog about trends in retail and consumer product businesses. He also appears regularly in print and other media as well as industry panels and speaking programs.  

Before co-founding Triangle, Richard was a Managing Director at a predecessor firm to Raymond James and before that he was a Partner and First Vice President at Drexel Burnham Lambert Inc.  At Drexel, Richard was responsible for a group of 14 professionals doing middle-market mergers and acquisitions around the world.

Richard is the co-author of three books on finance and computer programming.  He is formerly an Adjunct Assistant Professor of International Business at the graduate program of the Stern School of Business at New York University.  Richard received a BS in Accounting from New York University and an MBA with a concentration in Finance from Harvard University.  Richard is married and lives in New York.  

 

Kevin Weil

Chief Product Officer
OpenAI

Kevin Weil is Chief Product Officer at OpenAI, and a member of the Board of Directors of Cisco. In his current role as Chief Product Officer at OpenAI, Weil turns groundbreaking artificial intelligence research into practical, impactful solutions for over 500 million users, businesses, and developers globally. Prior to joining OpenAI, Weil served as the president of product and business for Planet Labs, cofounder of the Libra cryptocurrency, the vice president of product at Instagram, and the senior vice president of product at Twitter.

Kevin Weil

Chief Product Officer
OpenAI

Kevin Weil

Chief Product Officer
OpenAI

Kevin Weil is Chief Product Officer at OpenAI, and a member of the Board of Directors of Cisco. In his current role as Chief Product Officer at OpenAI, Weil turns groundbreaking artificial intelligence research into practical, impactful solutions for over 500 million users, businesses, and developers globally. Prior to joining OpenAI, Weil served as the president of product and business for Planet Labs, cofounder of the Libra cryptocurrency, the vice president of product at Instagram, and the senior vice president of product at Twitter.

 

Geoffrey Roth

Director Asset Management and Development
Keeper Bay Real Estate

Geoffrey Roth

Director Asset Management and Development
Keeper Bay Real Estate

Geoffrey Roth

Director Asset Management and Development
Keeper Bay Real Estate
 

Megan Stephens

Co-CEO & Owner
Willoughby Design

In her role as a brand strategist and agency co-owner following the purchase of Willoughby in 2016, Megan has led a large range of brand identity, consumer packaged goods and retail experience projects. Whether infusing new energy to help brands compete in the ever-changing marketplace or creating new brands from the ground up, she specializes in framing the business challenge, synthesizing the strategy, ideating solutions and then working with the design team to bring those ideas to life.

Megan Stephens

Co-CEO & Owner
Willoughby Design

Megan Stephens

Co-CEO & Owner
Willoughby Design

In her role as a brand strategist and agency co-owner following the purchase of Willoughby in 2016, Megan has led a large range of brand identity, consumer packaged goods and retail experience projects. Whether infusing new energy to help brands compete in the ever-changing marketplace or creating new brands from the ground up, she specializes in framing the business challenge, synthesizing the strategy, ideating solutions and then working with the design team to bring those ideas to life.

 
Beauty Connect LA 2025 (Archive)
3-5 Nov 2025
Fairmont Century Plaza – LA
Step into beauty & wellness' inner circle. Welcome to Beauty Connect, where the beauty and wellness industry’s most influential brands meet to innovate, collaborate, and grow.

Longevity science is going mainstream, and members want access to more than just workouts. We’ll explore how fitness brands are commercialising lab-backed tools like VO2 max testing, biological age tracking, hormone and metabolic panels, hyper-personalised recovery, and functional movement diagnostics to deliver on healthspan promises. Walk away with the playbook to package, price, and position these offerings for long-term loyalty and premium revenue.

Author:

Jeff Zwiefel

Executive Director
Life Time MIORA Longevity & Performance

Jeff Zwiefel is the former President and Chief Operating Officer of Life Time, where he played a pivotal role in shaping the company’s evolution over more than two decades. A nearly 40-year veteran in the fitness and wellness industry, Jeff has led large-scale operations and strategic growth initiatives that have helped redefine how health clubs deliver value to their members.

Now, Jeff is channeling his deep expertise and personal passion into the rapidly emerging field of longevity and healthy aging. He is currently partnering with Life Time to lead the development of MIORA — Longevity and Performance, a groundbreaking, science-backed program designed to optimize healthy aging through personalized, clinical-grade interventions.

MIORA represents the next frontier in Life Time’s ongoing mission to deliver a Healthy Way of Life. Building on the company’s 30+ years of leadership in fitness, nutrition, and wellness, MIORA brings together advanced diagnostics, hormone optimization, and performance-based lifestyle programming to empower individuals to live longer, healthier, and more vibrant lives.

https://www.Jeffzwiefel.com

https://www.podcastcollective.io/jeff-zwiefel-media-kit

Jeff Zwiefel

Executive Director
Life Time MIORA Longevity & Performance

Jeff Zwiefel is the former President and Chief Operating Officer of Life Time, where he played a pivotal role in shaping the company’s evolution over more than two decades. A nearly 40-year veteran in the fitness and wellness industry, Jeff has led large-scale operations and strategic growth initiatives that have helped redefine how health clubs deliver value to their members.

Now, Jeff is channeling his deep expertise and personal passion into the rapidly emerging field of longevity and healthy aging. He is currently partnering with Life Time to lead the development of MIORA — Longevity and Performance, a groundbreaking, science-backed program designed to optimize healthy aging through personalized, clinical-grade interventions.

MIORA represents the next frontier in Life Time’s ongoing mission to deliver a Healthy Way of Life. Building on the company’s 30+ years of leadership in fitness, nutrition, and wellness, MIORA brings together advanced diagnostics, hormone optimization, and performance-based lifestyle programming to empower individuals to live longer, healthier, and more vibrant lives.

https://www.Jeffzwiefel.com

https://www.podcastcollective.io/jeff-zwiefel-media-kit

Author:

Dr. Mark Kovacs

(former) Vice President of Health & Performance
Canyon Ranch

Dr. Mark Kovacs is a leader in the human performance, wellness & longevity fields. He previously served in senior executive roles at Canyon Ranch, Cleveland Cavaliers (NBA), Pepsico, Gatorade and the United States Tennis Association. He played a key role in developing next-generation solutions in longevity programming, biometric monitoring, predictive recovery and nutritional product development through science and education. He is recognized globally for his work at the intersection of human performance, wellness, sports, technology, and longevity. A former NCAA champion athlete and professional tennis player, he has worked with some of the top companies, brands athletes and executives with the goal of maximizing human performance. Dr. Kovacs advises Fortune 500 leaders, elite athletes, and organizations worldwide on durability, connected health, wellness, health and longevity infrastructure, equipment and facilities planning and design.

Dr. Mark Kovacs

(former) Vice President of Health & Performance
Canyon Ranch

Dr. Mark Kovacs is a leader in the human performance, wellness & longevity fields. He previously served in senior executive roles at Canyon Ranch, Cleveland Cavaliers (NBA), Pepsico, Gatorade and the United States Tennis Association. He played a key role in developing next-generation solutions in longevity programming, biometric monitoring, predictive recovery and nutritional product development through science and education. He is recognized globally for his work at the intersection of human performance, wellness, sports, technology, and longevity. A former NCAA champion athlete and professional tennis player, he has worked with some of the top companies, brands athletes and executives with the goal of maximizing human performance. Dr. Kovacs advises Fortune 500 leaders, elite athletes, and organizations worldwide on durability, connected health, wellness, health and longevity infrastructure, equipment and facilities planning and design.

Author:

Vanessa M Chu

Advisor and Chief Operation Officer
Extension Health

Vanessa M Chu

Advisor and Chief Operation Officer
Extension Health